Of Re 0.60 per share
Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 30 May 2014, inter alia, has recommended the payment of Dividend of Re 0.60 per equity share (@ 6%) of face value of Rs 10 each of the Company for the year 2013-14 subject to approval of the shareholders in the Annual General Meeting.Powered by Capital Market - Live News
